Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Circulation

• Publication date

  1999-06-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.99.22.2858PMID 10359727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation.

  1998cited by this paper
• Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries.

  1998cited by this paper
• Triglyceride‐ and Cholesterol‐Rich Lipoproteins Have a Differential Effect on Mild/Moderate and Severe Lesion Progression as Assessed by Quantitative Coronary Angiography in a Controlled Trial of Lovastatin

  1994cited by this paper
• Plasma Lipoproteins and Progression of Coronary Artery Disease Evaluated by Angiography and Clinical Events

  1993cited by this paper
• Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels.

  1993cited by this paper
• Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.

  1992cited by this paper
• Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

  1992cited by this paper
• Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway.

  1987cited by this paper
• WHO Expert Committee on Diabetes Mellitus: second report.

  1980cited by this paper

• Impact of remnant cholesterol on short-term mortality in acute decompensated heart failure: cohort study evidence from Jiangxi, China

  2025cites this paper
• Remnant cholesterol and associations with incidence, progression, and change in coronary artery calcium in South Asian Americans.

  2025cites this paper
• Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.

  2025cites this paper
• Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis

  2024cites this paper
• Significance of Circulating Remnant Lipoprotein Cholesterol Levels Measured by Homogeneous Assay in Patients with Type 2 Diabetes

  2023cites this paper
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

  2023cites this paper
• Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk

  2023cites this paper
• Sirt6 enhances macrophage lipophagy and improves lipid metabolism disorder by regulating the Wnt1/β-catenin pathway in atherosclerosis

  2023cites this paper
• Prognostic value of remnant cholesterol in patients with coronary heart disease: A systematic review and meta-analysis of cohort studies

  2023cites this paper
• The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

  2023cites this paper
• A realistic approach to evaluating the effect of baseline lipid profile in postcoronary artery bypass grafting surgery

  2023cites this paper
• Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan

  2022cites this paper
• Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis

  2022cites this paper
• Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA).

  2022cites this paper
• Serum esterified cholesterol subfractions as a risk marker for coronary artery disease

  2022cites this paper
• Elevated Remnant Lipoprotein Related to Adverse Events in Patients with Chronic Limb Threatening Ischemia after Endovascular Therapy for Below the Knee Lesions.

  2022cites this paper
• Association of remnant cholesterol and lipid parameters with new-onset carotid plaque in Chinese population

  2022cites this paper
• Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk

  2022cites this paper
• Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population

  2022cites this paper
• Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.

  2021cites this paper
• Effect of Remnant Lipoprotein Cholesterol and Nitric Oxide in Young Coronary Heart Disease Subjects

  2021cites this paper
• Association of triglyceride-rich lipoprotein-cholesterol with recurrent cardiovascular events in statin-treated patients according to different inflammatory status.

  2021cites this paper
• Correlation between estimated plasma remnant-like particle cholesterol and vegetable fat intake in Uku town, Japan

  2021cites this paper
• Predictive value of small dense low-density lipoprotein cholesterol for cardiovascular events in Chinese elder diabetes mellitus patients

  2021cites this paper
• Predictive Value of Small Dense Low-density Lipoprotein Cholesterol and Remnant-like Particle Cholesterol for Cardiovascular Events in Chinese Elder Diabetes Mellitus Patients

  2020cites this paper
• Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease

  2020cites this paper
• Effects of Dietary Blueberry (Vaccinium ashei Reade) Leaves on Mildly Postprandial Hypertriglyceridemia.

  2020cites this paper
• Prognostic impact of estimated remnant-like particle cholesterol in patients with differing glycometabolic status: an observational cohort study from China

  2020cites this paper
• Real-world analyses of patients with elevated atherosclerotic cardiovascular disease risk from the Optum Research Database.

  2020cites this paper
• Could remnant-like particle cholesterol become a risk factor in diabetic menopausal women with coronary artery disease? A cross-sectional study of single academic center in China

  2020cites this paper
• Prognostic Impact of Remnant-like Particle Cholesterol in Patients with Differing Glucose Metabolic Status: an Observational Cohort Study from China

  2020cites this paper
• The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes

  2020cites this paper
• Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease.

  2020cites this paper
• Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study

  2019cites this paper
• Remnant lipoproteins and atherosclerotic cardiovascular disease.

  2019cites this paper
• Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.

  2019cites this paper
• Changes in lipoprotein subfractions following menopause in the Longitudinal Study of Adult Health (ELSA-Brasil).

  2019cites this paper
• Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL.

  2019cites this paper
• Risk of cardiovascular events in patients with hypertriglyceridaemia: A review of real‐world evidence

  2019cites this paper
• Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids.

  2019cites this paper
• Comparison of Remnant Cholesterol Levels Estimated by Calculated and Measured LDL-C Levels in Chinese Patients with Coronary Heart Disease.

  2019cites this paper
• Very low-density lipoprotein cholesterol is associated with extent and severity of coronary artery disease in patients with type 2 diabetes mellitus

  2019cites this paper
• Effect of Combination Therapy of Ezetimibe and Atorvastatin on Remnant Lipoprotein Versus Double Atorvastatin Dose in Egyptian Diabetic Patients

  2018cites this paper
• Effect of exercise, diet and ethnicity on metabolic responses in postprandial state

  2018cites this paper
• Remnant-like particles and coronary artery disease in familial hypercholesterolemia.

  2018cites this paper
• The Effects of High-Protein and High-Monounsaturated Fat Meals on Postprandial Lipids, Lipoprotein Particle Numbers, Cytokines, and Leptin Responses in Overweight/Obese Subjects

  2018cites this paper
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

  2018cites this paper
• Small dense low‐density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease

  2018cites this paper
• Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease

  2018cites this paper
• Development of a Novel Homogeneous Assay for Remnant Lipoprotein Particle Cholesterol.

  2018cites this paper
• Activity-based targeting of secretory phospholipase A2 enzymes: A fatty-acid-binding-protein assisted approach.

  2017cites this paper
• Bone marrow transplantation in mice as a tool to study M2 macrophage activation in atherogenesis

  2017cites this paper
• Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patients

  2017cites this paper
• Empagliflozin decreases remnant‐like particle cholesterol in type 2 diabetes patients with insulin resistance

  2017cites this paper
• Low-density lipoprotein cholesterol lowering by adding ezetimibe to statin is associated with improvement of postprandial hyperlipidemia in diabetic patients with coronary artery disease

  2017cites this paper
• Effects of dipeptidyl peptidase-4 inhibitor sitagliptin on coronary atherosclerosis as assessed by intravascular ultrasound in type 2 diabetes mellitus with coronary artery disease

  2017cites this paper
• The impact of triglycerides on glucose tolerance: Lipotoxicity revisited.

  2017cites this paper
• Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation

  2017cites this paper
• Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.

  2017cites this paper
• Association of very Low-density Lipoprotein Cholesterol with All-cause and Cardiovascular Mortality in Peritoneal Dialysis

  2017cites this paper
• Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial)

  2017cites this paper
• VII．動脈硬化リスク・治療標的としてのTG，HDL

  2017cites this paper
• Postprandial Hyperlipidemia and Remnant Lipoproteins

  2017cites this paper
• Triglycerides and Risk rognostic Value of Remnant-Like Lipoprotein article Levels in Patients With Coronary rtery Disease and Type II Diabetes Mellitus

  2016cites this paper
• Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies

  2016cites this paper
• History and future of omega-3 fatty acids in cardiovascular disease

  2016cites this paper
• Lipids and apolipoproteins in cardiovascular disease

  2016cites this paper
• Activation of PPAR‐δ induces microRNA‐100 and decreases the uptake of very low‐density lipoprotein in endothelial cells

  2015cites this paper
• Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease

  2015cites this paper
• Leptin Hormone and Some Cardiac Biomarkers Among Congestive Heart Failure patients’ in Gaza Governorate – Palestine.

  2015cites this paper
• Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis.

  2015cites this paper
• Impact of Remnant Lipoprotein on Coronary Plaque Components.

  2015cites this paper
• Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study.

  2015cites this paper
• Clinical characteristics of Japanese patients with severe hypertriglyceridemia.

  2015cites this paper
• The effects of monounsaturated fatty acid-enriched diets with and without avocados on cardio-metabolic risk factors

  2015cites this paper
• Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins

  2015cites this paper
• Association of intima-media thickness of carotid arteries with remnant lipoproteins in men and women.

  2015cites this paper
• Effect of a Moderate Fat Diet With and Without Avocados on Lipoprotein Particle Number, Size and Subclasses in Overweight and Obese Adults: A Randomized, Controlled Trial

  2015influential citation
• New insights into the pathophysiology of dyslipidemia in type 2 diabetes.

  2015cites this paper
• Ongoing challenges for pharmacotherapy for dyslipidemia

  2015cites this paper
• Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.

  2014cites this paper
• Circulating PCSK9 is a strong determinant of plasma triacylglycerols and total cholesterol in homozygous carriers of apolipoprotein ε2.

  2014cites this paper
• Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals.

  2014cites this paper
• Clinical and economic outcomes in a real-world population of patients with elevated triglyceride levels.

  2014cites this paper
• High remnant lipoprotein predicts recurrent cardiovascular events on statin treatment after acute coronary syndrome.

  2014cites this paper
• Kidney function, cholesterol absorption and remnant lipoprotein accumulation in patients with diabetes mellitus.

  2014cites this paper
• Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation

  2014cites this paper
• Remnant Lipoproteins: A Subfraction of Plasma Triglyceride-Rich Lipoproteins Associated with Postprandial Hyperlipidemia

  2014cites this paper
• Postprandial hypertriglyceridemia as a coronary risk factor.

  2014cites this paper
• Remnant cholesterol as a causal risk factor for ischemic heart disease.

  2013cites this paper
• How Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?

  2013cites this paper
• High level of plasma remnant-like particle cholesterol may predispose to development of hypertension in normotensive subjects.

  2013cites this paper
• Metabolism of triglyceride-rich lipoproteins and transfer of lipids to high-density lipoproteins (HDL) in vegan and omnivore subjects.

  2013cites this paper
• A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL3+IDL])

  2013influential citation
• Elevated remnant lipoproteins may increase subclinical CVD risk in pre‐pubertal children with obesity: a case‐control study

  2013cites this paper
• Assessment of Leptin Hormone and Some Cardiac Biomarkers among Congestive Heart Failure patients' in Gaza Governorate - Palestine

  2013cites this paper
• Combination Lipid Therapy on Lipid Profiles in Patients with Impaired Glucose Tolerance

  2013cites this paper
• Effects of ezetimibe on atherogenic lipoproteins and glucose metabolism in patients with diabetes and glucose intolerance.

  2013cites this paper
• A hypertriglyceridemic state increases high sensitivity C-reactive protein of Japanese men with normal glucose tolerance

  2012cites this paper
• Lipids, Atherogenic Dyslipidemia, and Therapy

  2012cites this paper